The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
